GSTM1 and bone metastasis: Figure 1 showed the distribution of G6PD activity levels between patients with and without bone metastasis. The group with bone metastasis showed a median G6PD activity level of 12.2 U/g Hb, whereas the group without bone metastasis had a median level of 10.0 U/g Hb (Figure 1).